CLINICAL_TRIALS
research
· 2017-12-12
Clinical Trial Update: DWP450 Treatment in Subjects With Benign Masseteric Hypertrophy [Phase 2]
Summary
Phase 2 clinical trial update for DWP450 in benign masseteric hypertrophy; current status is unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Benign Masseteric Hypertrophy | Phase 2 | Status: UNKNOWN